These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32920645)

  • 1. Thrombolysis as first-line therapy for Medtronic/HeartWare HVAD left ventricular assist device thrombosis.
    Dimitrov K; Maier J; Sandner S; Riebandt J; Wiedemann D; Moayedifar R; Schlöglhofer T; Angleitner P; Niederdöckl J; Schima H; Tschernko E; Laufer G; Zimpfer D
    Eur J Cardiothorac Surg; 2020 Dec; 58(6):1182-1191. PubMed ID: 32920645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conservative approaches for HeartWare ventricular assist device pump thrombosis may improve the outcome compared with immediate surgical approaches.
    Saeed D; Maxhera B; Albert A; Westenfeld R; Hoffmann T; Lichtenberg A
    Interact Cardiovasc Thorac Surg; 2016 Jul; 23(1):90-5. PubMed ID: 26993475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of device thrombus in the HeartWare HVAD: Success and outcomes depend significantly on the initial treatment strategy.
    Stulak JM; Dunlay SM; Sharma S; Haglund NA; Davis MB; Cowger J; Shah P; Masood F; Aaronson KD; Pagani FD; Maltais S
    J Heart Lung Transplant; 2015 Dec; 34(12):1535-41. PubMed ID: 26681123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of thrombolytic therapy in patients with HeartWare ventricular assist device thrombosis: a single-institutional experience.
    Fox H; Gyoten T; Rojas SV; Lauenroth V; Günther S; Schramm R; Gummert JF; Morshuis M
    Interact Cardiovasc Thorac Surg; 2022 Jun; 35(1):. PubMed ID: 35234899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombus on the inflow cannula of the HeartWare HVAD: an update.
    Glass CH; Christakis A; Fishbein GA; Watkins JC; Strickland KC; Mitchell RN; Padera RF
    Cardiovasc Pathol; 2019; 38():14-20. PubMed ID: 30399526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Experience of HeartMate II to HeartWare Left Ventricular Assist Device Exchange: A Multicenter Experience.
    Agarwal R; Kyvernitakis A; Soleimani B; Milano CA; Davis RP; Kennedy JL; Yarboro L; Benza RL; Moraca RJ; Bailey SH
    Ann Thorac Surg; 2019 Oct; 108(4):1178-1182. PubMed ID: 31059685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of characteristics, risk factors, and predictors of recurrent LVAD thrombosis: conditions in HeartWare devices.
    Gyoten T; Morshuis M; Rojas SV; Deutsch MA; Schramm R; Gummert JF; Fox H
    J Artif Organs; 2021 Jun; 24(2):173-181. PubMed ID: 33337536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and Management of Pump Thrombus in the HeartWare Left Ventricular Assist Device System: A Novel Approach Using Log File Analysis.
    Jorde UP; Aaronson KD; Najjar SS; Pagani FD; Hayward C; Zimpfer D; Schlöglhofer T; Pham DT; Goldstein DJ; Leadley K; Chow MJ; Brown MC; Uriel N
    JACC Heart Fail; 2015 Nov; 3(11):849-56. PubMed ID: 26454842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial.
    Najjar SS; Slaughter MS; Pagani FD; Starling RC; McGee EC; Eckman P; Tatooles AJ; Moazami N; Kormos RL; Hathaway DR; Najarian KB; Bhat G; Aaronson KD; Boyce SW;
    J Heart Lung Transplant; 2014 Jan; 33(1):23-34. PubMed ID: 24418731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective treatment with a new protocol using tissue-type plasminogen activator thrombolysis for pump thrombosis with the HVAD device.
    Schrage B; Grahn H; Wagner FM; Bernhardt A; Rybczynski M; Blankenberg S; Reichenspurner H; Barten MJ
    Eur Heart J Acute Cardiovasc Care; 2018 Dec; 7(8):766-770. PubMed ID: 28058856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HVAD to HeartMate 3 left ventricular assist device exchange: Best practices recommendations.
    Salerno CT; Hayward C; Hall S; Goldstein D; Saeed D; Schmitto J; Kaczorowski D; Molina E; Zimpfer D; Tsui S; Soltesz E; Pham DT; Mokadam NA; Kilic A; Davis E; Feller E; Lorts A; Silvestry S; Slaughter MS; Potapov E; Atluri P; Cowger J; Pagani FD;
    J Thorac Cardiovasc Surg; 2022 Jun; 163(6):2120-2127.e5. PubMed ID: 35341579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do patients with the centrifugal flow HeartMate 3 or HeartWare left ventricular assist device have better outcomes compared to those with axial flow HeartMate II?
    Florisson DS; Conte SM; De Bono JA; Newcomb AE
    Interact Cardiovasc Thorac Surg; 2019 Dec; 29(6):844-851. PubMed ID: 31436825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial conservative management strategy of HeartWare left ventricular assist device thrombosis with intravenous heparin or bivalirudin.
    Bouzas-Cruz N; Gonzalez-Fernandez O; Ferrera-Durán C; Woods A; Robinson-Smith N; Tovey S; Jungschleger J; Booth K; Shah A; Parry G; MacGowan GA; Schueler S
    Int J Artif Organs; 2020 Jul; 43(7):444-451. PubMed ID: 31885316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HVAD to HeartMate 3 left ventricular assist device exchange: Best practices recommendations.
    Salerno CT; Hayward C; Hall S; Goldstein D; Saeed D; Schmitto J; Kaczorowski D; Molina E; Zimpfer D; Tsui S; Soltesz E; Pham DT; Mokadam NA; Kilic A; Davis E; Feller E; Lorts A; Silvestry S; Slaughter MS; Potapov E; Atluri P; Cowger J; Pagani FD;
    Eur J Cardiothorac Surg; 2022 Jun; 62(1):. PubMed ID: 35325091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Third Generation Ventricular Assist Device: Mid-Term Outcomes of the HeartWare HVAD in Pediatric Patients.
    Pac M; Kocabeyoglu SS; Kervan U; Sert DE; Koca S; Ece I; Pac FA
    Artif Organs; 2018 Feb; 42(2):141-147. PubMed ID: 29032583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombosis in Continuous Flow Left Ventricular Assist Devices: Our Clinical Experience With Medical and Surgical Management.
    Köksel U; Erbasan O; Bayezid Ö; Kemaloğlu C; Özçobanoğlu S; Gölbaşı I; Türkay C
    Transplant Proc; 2016; 48(6):2162-7. PubMed ID: 27569964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of aortic valve closure on adverse events and outcomes with the HeartWare ventricular assist device.
    Dobarro D; Urban M; Booth K; Wrightson N; Castrodeza J; Jungschleger J; Robinson-Smith N; Woods A; Parry G; Schueler S; MacGowan GA
    J Heart Lung Transplant; 2017 Jan; 36(1):42-49. PubMed ID: 27776988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HVAD to HeartMate 3 Left Ventricular Assist Device Exchange: Best Practices Recommendations.
    Salerno CT; Hayward C; Hall S; Goldstein D; Saeed D; Schmitto J; Kaczorowski D; Molina E; Zimpfer D; Tsui S; Soltesz E; Pham DT; Mokadam NA; Kilic A; Davis E; Feller E; Lorts A; Silvestry S; Slaughter MS; Potapov E; Atluri P; Cowger J; Pagani FD;
    Ann Thorac Surg; 2022 Jun; 113(6):1770-1777. PubMed ID: 35341592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrograde washout of prepump LVAD thrombosis in a patient on HeartWare™ support.
    Elbayomi M; Weyand M; Heim C; Steger K; Tandler R
    J Card Surg; 2022 Oct; 37(10):3440-3442. PubMed ID: 35894824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of preoperative atrial fibrillation on thromboembolic events and pump thrombosis in long-term left ventricular assist device therapy.
    Pedde D; Soltani S; Stein J; Tsyganenko D; Müller M; Schönrath F; Falk V; Potapov EV
    Eur J Cardiothorac Surg; 2020 Feb; 57(2):325-330. PubMed ID: 31317177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.